Quantcast

Hi-Tech Pharmacal Wins Final Approval for Ocular Hypertension Drug

October 30, 2008

Hi-Tech Pharmacal, a specialty pharmaceutical company, has announced that the FDA has granted final approval to the company’s abbreviated new drug application for dorzolamide and timolol ophthalmic solution, the generic for Merck’s Cosopt.

The product is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta blockers. Hi-Tech plans to launch generic dorzolamide and timolol ophthalmic solution immediately.




comments powered by Disqus